PCRX vs RARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
PCRX
RARE
Investment Advisor Scores
RARE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | RARE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.25 | 0 | Tie |
| PEG Ratio | 11.2121 | -0.24 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | 28.1% | RARE |
| Earnings Growth | -30.0% | 0.0% | RARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 58.6/100 | 52.5/100 | PCRX |
| Profit Margin | 2.0% | -81.7% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
NeutralMixed signals - no dominant trend phase, RSI 51
RARE
MarkdownPrice below a falling SMA50 (slope -24.3%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | PCRX | RARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.3 | 22.5 |
| Trailing P/E | 71.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.3% |
| Gross Margin | 0.8% | -0.2% |
| Operating Margin | 0.1% | -0.4% |
| EPS | 0.35 | -5.72 |
| Dividend Yield | — | — |